This study employs perfusion and diffusion weighted imaging (PDWI) at 21.1 T to identify the pattern of potential recovery of cerebral blood flow (CBF) and apparent diffusion coefficient (ADC) in ischemic stroke with a novel stem cell therapy using dissociated aggregate human mesenchymal stem cells (d-hMSC) in a rodent stroke model. Spanning a week post ischemia, high field MRI was performed with the goal of quantitatively assessing treatment efficacy longitudinally. Results show longer term increase of ADC in the ischemic region and shorter term CBF stabilization in the contralateral region.
This abstract and the presentation materials are available to members only; a login is required.